113 related articles for article (PubMed ID: 22780299)
1. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.
Tang W; Zhou X; Nie S; Yang Z; Zhu H; Wu X; Zhao R; Luo Y
Biomarkers; 2012 Nov; 17(7):597-603. PubMed ID: 22780299
[TBL] [Abstract][Full Text] [Related]
2. Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis.
Yang Z; Nie S; Zhu H; Wu X; Jia S; Luo Y; Tang W
Gene; 2013 Jan; 512(2):408-13. PubMed ID: 23073555
[TBL] [Abstract][Full Text] [Related]
3. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
4. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies.
Zhao L; Zhao X; Wu X; Tang W
Genet Test Mol Biomarkers; 2013 Oct; 17(10):721-6. PubMed ID: 23844939
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between p53 codon 72 polymorphism and endometrial cancer: a meta-analysis.
Tang W; He X; Chan Y; Luo Y
Cancer Epidemiol; 2012 Jun; 36(3):e153-7. PubMed ID: 22277327
[TBL] [Abstract][Full Text] [Related]
6. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
[TBL] [Abstract][Full Text] [Related]
7. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
[TBL] [Abstract][Full Text] [Related]
8. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
9. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
Wu B; Guo D; Guo Y
Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
[TBL] [Abstract][Full Text] [Related]
10. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.
Gu Y; Zhou X; Zhang SL
Genet Mol Res; 2011 Oct; 10(4):3609-19. PubMed ID: 22057999
[TBL] [Abstract][Full Text] [Related]
12. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis.
Zhang Y; Zhang D; Zhao L; Sun L; Dong Q; Cheng L; Cheng R
Curr Probl Cancer; 2018 Nov; 42(6):582-592. PubMed ID: 30316510
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Jiang DK; Ren WH; Yao L; Wang WZ; Peng B; Yu L
Urology; 2010 Sep; 76(3):765.e1-7. PubMed ID: 20630574
[TBL] [Abstract][Full Text] [Related]
15. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
[TBL] [Abstract][Full Text] [Related]
16. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls.
Ni M; Qiu J; He W; Wang X
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):683-7. PubMed ID: 22343785
[TBL] [Abstract][Full Text] [Related]
17. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
[TBL] [Abstract][Full Text] [Related]
18. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
[TBL] [Abstract][Full Text] [Related]
19. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
[TBL] [Abstract][Full Text] [Related]
20. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
Xiang B; Mi YY; Li TF; Liu PF
Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
